$22MSeries C, 17 June 2025
Closed a $22M Series C and named Tom Willis CEO to launch a pipeline of clinical assays.
- Amount
- $22M
- Stage
- Series C
- Announced
- 17 June 2025
- Lead
- Illumina Ventures
- Other investors
- Co-Win Ventures, Berkeley Catalyst Fund
- Use of funds
- Closed a $22M Series C and named Tom Willis CEO to launch a pipeline of clinical assays.
- Checked
- Amount and date checked against the press source
- Source
- Arima Genomics closes $22M Series C (date approx) pulse2.com